Remove Clinical Research Remove Doctors Remove Genetics Remove Immune Response
article thumbnail

STAT+: Foundation charges cancer patients $83,000 for unproven but promising experimental drug

STAT News

But they said the sum covers only the direct costs of designing and manufacturing the vaccines ― which are tailored to the unique genetic makeup of each patient’s tumor ― and that the FDA has approved the breakdown of expenses. A doctor at Duke was skeptical and would not administer the shots, Kielty said.

article thumbnail

Who are the AACR Scientific Achievement Award winners?

Drug Discovery World

Carl H June, MD, FAACR – Lifetime Achievement in Cancer Research June, a Fellow of the AACR Academy, is the Richard W Vague Professor in Immunotherapy, Director of the Center for Cellular Immunotherapies, and Director of the Parker Institute for Cancer Immunotherapy in the Perelman School of Medicine at the University of Pennsylvania.

article thumbnail

COVID-19 Pandemic Coverage

XTalks

It was recently reported that the addition of an adjuvant to their vaccine led to enhanced immune responses that exceeded responses in convalescent serum from symptomatic COVID-19 patients. Several laboratories have already shown that they can detect genetic material from the virus in wastewater.